Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-047746
Filing Date
2021-09-13
Accepted
2021-09-13 18:06:39
Documents
1
Period of Report
2021-09-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 4032
  Complete submission text file 0001213900-21-047746.txt   5584
Mailing Address C/O KALEIDO BIOSCIENCES, INC. 65 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
SCULLEY JOHN (Reporting) CIK: 0001015816 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38914 | Film No.: 211250681

Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Issuer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations